Quantitative dynamics of HIV type 1 expression

AIDS Research and Human Retroviruses

Volumn 12, Issue 2, 1996, Pages 117-126

  Comar, Manola ^a   Marzio, Giuseppe ^a   D'Agaro, Pierlanfranco ^b   Giacca, Mauro ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMID DNA; VIRUS DNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DYNAMICS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; VIRUS EXPRESSION; VIRUS GENOME;

EID: 0030033603     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.117     Document Type: Article

References (52)

1. Michael NL, Vahey M, Burke DS, and Redfield RR: Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease. J Virol 1992;66:310-316.
2. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, and Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 1993;362:355-358.
3. Gupta P, Enrico A, Armstrong J, Doerr M, Ho M, and Rinaldo C: A semiquantitative microassay for measurement of relative number of blood mononuclear cells infected with human immunodeficiency virus. AIDS Res Hum Retrov 1990;6:1193-1196.
4. Connor RI, Mohri H, Cao Y, and Ho DD: Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 1993;67:1772-1777.
5. Gupta P, Kingsley L, Armstrong J, Ding M, Cottrill M, and Rinaldo C: Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS. Virology 1993;196:586-595.
6. Schnittman SM, Greenhouse JJ, Psallidopoulos MC, Baseler M, Salzman NP, Fauci AS, and Lane HC: Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med 1990;113:438-443.
7. Simmonds P, Balfe P, Peutherer JF, Ludlam CA, Bishop JO, and Brown AJ: Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol 1990;64:864-872.
8. Jurriaans S, Dekker JT, and de Ronde A: HIV-1 viral DNA load in peripheral blood mononuclear cells from seroconverters and long-term infected individuals. AIDS 1992;6:635-641.
9. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, and Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 1993;362:359-362.
10. Bagnarelli P, Menzo S, Valenza A, Manzin A, Giacca M, Ancarani F, Scalise G, Varaldo PE, and Clementi M: Molecular profile of human immunodeficiency virus infection in asymptomatic subjects and AIDS patients. J Virol 1992;66:7328-7335.
11. Menzo S, Bagnarelli P, Giacca M, Manzin A, Varaldo PE, and Clementi M: Absolute quantitation of viremia in HIV-infected asymptomatic subjects by competitive reverse-transcription and polymerase chain reaction. J Clin Microbiol 1992;30:1752-1757.
12. Scadden DT, Wang Z, and Groopman JE: Quantitation of plasma human immunodeficiency virus type 1 RNA by competitive polymerase chain reaction. J Infect Dis 1992;165:1119-1123.
13. Piatak M Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk K-C, Hahn BH, Shaw GM, and Lifson JD: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-1754.
14. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, and Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 1995;373:123-126.
15. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, and Shaw GM: Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 1995;373:117-122.
16. Saksela K, Stevens C, Rubinstein P, and Baltimore D: Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Proc Natl Acad Sci USA 1994;91:1104-1108.
17. Robert-Guroff M, Popovic M, Gartner S, Markham P, Gallo RC, and Reitz MS: Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J Virol 1990;64:3391-3398.
18. Schwartz S, Felber BK, Benko DM, Fenyo EM, and Pavlakis GN: Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol 1990; 64:2519-2529.
19. Schwartz S, Felber BK, Fenyo EM, and Pavlakis GN: Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J Virol 1990;64:5448-5456.
20. Kim S, Byrn R, Groopman J, and Baltimore D: Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: Evidence for differential gene expression. J Virol 1989;63:3708-3713.
21. Klotman ME, Kim S, Buchbinder A, DeRossi A, Baltimore D, and Wong-Staal F: Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc Natl Acad Sci USA 1991; 88:5011-5015.
22. Pomerantz RJ, Trono D, Feinberg MB, and Baltimore D: Cells non-productively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency. Cell 1990;61:1271-1276.
23. Michael NL, Morrow P, Mosca J, Vahey M, Burke DS, and Redfield RR: Induction of human immunodeficiency virus type 1 expression in chronically infected cells is associated primarily with a shift in RNA splicing patterns. J Virol 1991;65:1291-1303.
24. Cullen BR, and Greene WC: Regulatory pathways governing HIV-1 replication. Cell 1989;58:423-426.
25. Pomerantz RJ, Seshamma T, and Trono D: Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: Potential implications for latency. J Virol 1992; 66:1809-1813.
26. Schnittman SM, Greenhouse JJ, Lane HC, Pierce PF, and Fauci AS: Frequent detection of HIV-1-specific mRNAs in infected individuals suggests ongoing active viral expression in all stages of disease. AIDS Res Hum Retroviruses 1991;7:361-367.
27. Seshamma T, Bagasra O, Trono T, Baltimore D, and Pomerantz RJ: Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1992;89:10663-10667.
28. Diviacco S, Norio P, Zentilin L, Menzo S, Clementi M, Biamonti G, Riva S, Falaschi A, and Giacca M: A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene 1992;122:313-320.
29. Giacca M, Zentilin L, Norio P, Diviacco S, Dimitrova D, Contreas G, Biamonti G, Perini G, Weighardt F, Riva S, and Falaschi A: Fine mapping of a replication origin of human DNA. Proc Natl Acad Sci USA 1994;91:7119-7123.
30. Grassi G, Zentilin L, Tafuro S, Diviacco S, Ventura A, and Giacca M: A rapid procedure for the quantitation of low abundance mRNAs by competitive RT-PCR. Nucleic Acids Res 1994; 22:4547-4549.
31. Sestini R, Orlando C, Zentilin L, Gelmini S, Pinzani P, Giacca M, and Pazzagli M: Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction. Clin Chem 1994;40:630-636.
32. Grassi G, Pozzato G, Moretti M, and Giacca M: Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction. J Hepatol 1995; 23:403-411.
33. Sestini R, Orlando C, Zentilin L, Lami D, Gelmini S, Pinzani P, Giacca M, and Pazzagli M: Measurement of gene amplification for c-erB-2, c-myc, epidermal growth factor receptor, int-2 and N-myc by quantitative PCR with a multiple competitor template. Clin Chem 1995;41:826-832.
34. Saiki R, Gelfand D, Stoffel S, Scharf S, Higuchi R, Horn G, Mullis K, and Erlich H: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-491.
35. Folks TM, Justement J, Kinter A, Dinarello CA, and Fauci AS: Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987;238:800-802.
36. Folks TM, Justement J, Kinter A, Schnittman S, Orenstein J, Poli G, and Fauci AS: Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J Immunol 1988;140:1117-1122.
37. Sambrook J, Fritsch EF, and Maniatis T: Molecular Cloning. A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989.
38. Chomczynski P, and Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
39. Guatelli JC, Gingeras TR, and Richman DD: Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells. J Virol 1990;64:4093-4098.
40. Higuchi R, Krummel B, and Saiki RK: A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 1988;16:7351-7367.
41. Ho SN, Hunt HD, Horton RM, Pullen JK, and Pease LR: Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989;77:51-59.
42. Demarchi F, D'Agaro P, Falaschi A, and Giacca M: In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1. J Virol 1993;67:7450-7460.
43. Kinter AL, Poli G, Maury W, Folks TM, and Fauci AS: Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J Virol 1990;64:4306-4312.
44. Poli G, Kinter A, Justement JS, Kehrl JH, Bressler P, Sharilyn S, and Fauci AS: Tumor necrosis factor α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA 1990;87:782-785.
45. Arrigo SJ, Weitsman S, Rosenblatt JD, and Chen IS: Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method. J Virol 1989;63:4875-4881.
46. Siebert PD, and Larrick JW: Competitive PCR. Nature (London) 1992;359:557-558.
47. Bagnarelli P, Valenza A, Menzo S, Manzin A, Salise G, Varaldo PE, and Clementi M: Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. J Virol 1994;68:2495-2502.
48. Amendt BA, Hesslein D, Chang LJ, and Stoltzfus CM: Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol Cell Biol 1994;14:3960-3970.
49. Chen B, Saksela K, Andino R, and Baltimore D: Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J Virol 1994;68:654-660.
50. Adams M, Sharmeen L, Kimpton J, Romeo JM, Garcia JV, Peterlin BM, Groudine M, and Emerman M: Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc Natl Acad Sci USA 1994;91:3862-3866.
51. Cannon P, Kim SH, Ulich C, and Kim S: Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2. J Virol 1994;68:1993-1997.
52. Duan L, Oakes JW, Ferraro A, Bagasra O, and Pomerantz RJ: Tat and Rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells. Virology 1994;199:474-478.